Erythropoietin (EPO) treatment for anemia of prematurity is still controversial. Large multicentric trials demonstrate that administration of EPO+Fe cannot prevent early transfusions, particularly in very low birth weight newborns and in infants with severe neonatal diseases, but may have some beneficial effect to prevent late transfusions...
Keywords: Anemia, blood transfusion, erythropoietin, prematurity
07/2005 | Journal of Perinatal Medicine, Walter de Gruyter